Saracatinib Trial TO Prevent FOP | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Saracatinib Trial TO Prevent FOP	fibrodysplasia ossificans progressiva, muscle tissue disorder, musculoskeletal system disorder, myositis disease, myositis ossificans	Active, not recruiting	Phase 2	2026-09-02		NCT04307953

7 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Amsterdam UMC, location VUmc	102
AstraZeneca	806
Brigham and Women's Hospital	378
Innovative Medicines Initiative	6
Klinikum Garmisch-Patenkirchen	1
Royal National Orthopaedic Hospital NHS Trust	10
University of Oxford	213

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Amsterdam University Medical Center	Amsterdam	Netherlands	2
Klinikum Garmish-Partenkirchen	Garmisch-Partenkirchen	Germany	1
Royal National Orthopaedic Hospital	London	United Kingdom	3